Provider
QP25-22 Reminder for New to Market Medical Drugs: Medical Drug Evaluation Process List
Program effective Date: Apr 13, 2022
Documents & Forms Results
Displaying 2391 - 2400 of 3590 results
Provider
QP26-22 Provider Directory Validation (PDV) Tool
Program effective Date: Apr 13, 2022
Provider
QP27-22 MHCP Pharmacy Benefit Exclusion for Fyarro
Program effective Date: Apr 13, 2022
Provider
QP28-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit ( QL) Criteria: OpzeluraTM (ruxolitnib)
Program effective Date: Apr 13, 2022
Provider
QP29-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TavneosTM (avacopan)
Program effective Date: Apr 13, 2022
Provider
QP30-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TyrvayaTM (varenicline)
Program effective Date: Apr 13, 2022
Provider
P17-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options Prior Authorization and Medical Policy Requirements
Program effective Date: Apr 01, 2022
Provider
P18-22 Non-Covered Procedure Codes for Minnesota Health Care Programs
Program effective Date: Apr 01, 2022
Provider
P19-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Program effective Date: Apr 01, 2022
Provider
P20-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates — Effective June 6, 2022
Program effective Date: Apr 01, 2022